Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

Effects of Antiatherosclerosis in Carotid Artery by Rnai-Mediated Silencing of Mcp-1 Expression

Effets De L'inhibition De L'expression De MCP-1 Médiée Par ARNi Sur L'athérosclérose Carotidienne.

Efectos Antiaterogénicos De La Inhibición De La Expresión De MCP-1 Mediada Por ARNi

Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.

Enhanced Local Delivery of Microrna-145A-5p into Mouse Aorta Via Ultrasound-Targeted Microbubble Destruction Inhibits Atherosclerotic Plaque Formation.

Abstract 237: the Inhibitory Effect on Vascular Smooth Muscle Cell Hyperplasia in Artificial Atherosclerotic Mouse Model Via Mir-155 Induced NoxA1 Down Regulation

Silencing MR-1 attenuates atherosclerosis in ApoE-/- mice induced by angiotensin II through FAK-Akt-mTOR-NF-kappaB signaling pathway

Inhibited Atherosclerotic Plaque Formation by Local Administration of Magnetically Labeled Endothelial Progenitor Cells (epcs) in a Rabbit Model.

Suppression of Circdcbld1 Alleviates Intimal Hyperplasia in Rat Carotid Artery by Targeting Mir-145-3p/neuropilin-1

Effects of Antisense Oligonucleotides Against C-Reactive Protein on the Development of Atherosclerosis in WHHL Rabbits

Silencing of circARHGAP12 inhibits the progression of atherosclerosis via miR-630/EZH2/TIMP2 signal axis

Construction eukaryotic expression vector of MCP-1 siRNA

Effect of Lipanthyl on Mrna Expression of Endothelin-1 and Nitric-Oxide Synthase in Atherosclerotic Vessel Wall in Rabbits.

Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model.

The Effects of Mir-467B on Lipoprotein Lipase (LPL) Expression, Pro-Inflammatory Cytokine, Lipid Levels and Atherosclerotic Lesions in Apolipoprotein E Knockout Mice

Systemically Silencing Long Non-coding RNAs Maclpil With Short Interfering RNA Nanoparticles Alleviates Experimental Ischemic Stroke by Promoting Macrophage Apoptosis and Anti-inflammatory Activation

Lentiviral-mediated RNA Interference of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice

Effects of lentivirus-mediated angiopoietin-1 gene modified bone marrow mesenchymal stem cells transplantation on carotid atherosclerosis

Inhibition of CIRBP represses the proliferation and migration of vascular smooth muscle cells via inhibiting Rheb/mTORC1 axis